The FDA has launched a review of clinical trials that plan to send American citizens' living cells to 'hostile' countries – including China – for genetic modification. The just-announced initiative is ...
When it comes to CGT trials, teams are dealing with more than typical clinical study challenges. These trials represent a whole new complexity, where every treatment is as unique as the patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback